HEREDITARY CANCER
Hereditary DNA Genetic Cancer Risk Test

98 Genes | 25 Cancers
Determine patient risk for 25 types of hereditary cancers. The most comprehensive hereditary cancer test available.

Sample Type:          Saliva or Blood
Suitable For:           All Individuals
Lab Certification:  CAP / CLIA
TAT:                          <25 days upon receipt of sample at CMX Laboratory

Hereditary Breast Cancer Risk Test

BRCA 1 & BRCA 2 PLUS 13 GENES
The most comprehensive hereditary breast cancer.

Sample Type:          Saliva or Blood
Suitable For:           Individuals who want to know the risk of breast, ovarian or pancreatic cancers.
Lab Certification:  CAP / CLIA
TAT:                          <25 days upon receipt of sample at CMX Laboratory

EARLY CANCER DETECTION
CRC Protect Test - Colorectal Cancer

Circulating Tumor Cell (CTC) identification
The most sensitive blood test for the detection of early stage colorectal cancer and precancerous lesions when disease is most curable.

Sample Type:          Blood
Suitable For:           Individuals diagnosed with cancer
Lab Certification:  CAP / CLIA
TAT:                          <10 days upon receipt of sample at CMX Laboratory

Prostate Cancer Test

Circulating Tumor Cell (CTC) identification
Precise routine blood test that clarifies whether a patient can avoid painful diagnostics biopsy following inconclusive/grey-zone results from PSA testing.

Sample Type:         Blood
Suitable For:          Men never diagnosed with prostate cancer
Lab Certification:  CAP / CLIA
TAT:                          <10 days upon receipt of sample at CMX Laboratory

CANCER RECURRENCE MONITORING
PanCa Monitor CTC Blood Test

Circulating Tumor Cell (CTC) identification
Non- invasive, radiation-free, routine recurrence monitoring for 17 different types of cancers

Sample Type:          Blood
Suitable For:           Individuals diagnosed with any one of the 17 cancers covered
Lab Certification:  CAP / CLIA
TAT:                          <10 days upon receipt of sample at CMX Laboratory

SOMATIC CANCER
PD-L1 CTC Test

Simple blood test. PD-L1 expression using CTC to determine eligibility for immunotherapy

Sample Type:         Blood
Suitable For:          Cancer Patients
Lab Certification:  CAP / CLIA
TAT:                          <10 days upon receipt of sample at CMX Laboratory

LBx Liquid Biopsy Test

73 Genes & MSI
Analyzes majority of solid tumours for targeted and immunotherapy selection, treatment monitoring and management solutions. Most comprehensive and the only NCCN complete clinical liquid biopsy test to detect somatic alterations (SNVs, INDELS, CNAs, Fusions & MSI)

Sample Type:         Blood
Suitable For:          Cancer Patients
Lab Certification:  CAP / CLIA
TAT:                          <28 days upon receipt of sample at CMX Laboratory

 

TBx Tissue Biopsy Test

73 genes & MSI
Analyzes all solid tumours for targeted and immunotherapy selection. Most comprehensive and NCCN guideline complete test to detect somatic alterations (SNVs, INDELS, CNAs, Fusions & MSI)

Sample Type:         FFPE Tissue
Suitable For:          Cancer Patients
Lab Certification:  CAP / CLIA
TAT:                          <28 days upon receipt of sample at CMX Laboratory

NCCN Lung Cancer LBx

The only NCCN guideline complete test for biopsy for immunotherapy and targeted therapy selection for patients with lung cancer. Most comprehensive and NCCN guideline complete test to detect somatic alterations (SNVs, INDELS, CNAs, Fusions & MSI)

Sample Type:         Blood
Suitable For:          Lung Cancer
Lab Certification:  CAP / CLIA
TAT:                          <28 days upon receipt of sample at CMX Laboratory

NCCN Lung Cancer LBx_PD-L1 CTC Blood Test

The only NCCN guideline complete test for biopsy for immunotherapy and targeted therapy selection for patients with lung cancer. Most comprehensive and NCCN guideline complete test to detect somatic alterations (SNVs, INDELS, CNAs, Fusions & MSI) & PD-L1 CTC

Sample Type:         Blood
Suitable For:          Lung Cancer
Lab Certification:  CAP / CLIA
TAT:                          <28 days upon receipt of sample at CMX Laboratory